Edwards Lifesciences Corporation: Provider of Innovative Products and Solutions for Structural Heart Disease Edwards Lifesciences Corporation, a global leader in medical technology, offers an extensive range of products and technologies for structural heart disease, critical care, and surgical monitoring in the United States, Europe, Japan, and internationally. With its headquarters based in Irvine, California and founded in 1958, the company has established itself as a trusted name in the healthcare industry. The company's transcatheter heart valve replacement products have been highly sought after for their minimally invasive approach in the replacement of heart valves. Additionally, Edwards Lifesciences Corporation provides transcatheter heart valve repair and replacement products which are used to treat mitral and tricuspid valve diseases. In its pursuit to provide innovative solutions, the company offers PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. Under its surgical structural heart solutions, Edwards Lifesciences Corporation offers aortic surgical valve under the INSPIRIS name, KONECT RESILIA, which is a pre-assembled aortic tissue valved conduit for patients requiring replacement of the valve, root, and ascending aorta, and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. These solutions have proved to be highly effective in their respective fields and have helped the company establish a significant presence in the market. Moreover, the company also provides critical care solutions, including advanced hemodynamic monitoring systems that measure a patient's heart function and fluid status in surgical and intensive care settings. The Acumen Hypotension Prediction Index software, another innovative offering from Edwards Lifesciences Corporation, alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products worldwide through a direct sales force and independent distributors, bolstering its position as a leader in the industry. With its focus on innovation and superior patient care, Edwards Lifesciences Corporation remains committed to introducing advanced products and technologies to the market.